Question 1

What’s the biggest challenge facing the cannabis industry right now, and how are you and/or your company addressing it?

One of the biggest challenges facing the cannabis industry today is the ongoing lack of federal clarity—particularly around tax treatment, banking access, and interstate commerce. That uncertainty amplifies compliance risk, increases operating costs, and restricts capital access for both startups and established operators.

At Tuross Group, we work with over 40 cannabis clients across cultivation, manufacturing, distribution, and retail, and we see how this regulatory environment affects the bottom line every day. From burdensome 280E restrictions to inconsistent state reporting requirements, operators are forced to navigate a financial and compliance minefield without the infrastructure that more traditional industries take for granted.

Our response is two-fold: First, we build out bulletproof financial systems that ensure compliance is embedded into every transaction—from inventory costing to tax strategy. We leverage Section 471(c), when applicable, and design our clients’ chart of accounts to optimize deductions while staying squarely within the IRS’s tolerance levels.

Second, we deliver 24-hour current financial data to operators—giving them a real-time understanding of their cash flow, cost of goods, and profitability by location or product. That clarity is a game changer in an industry where decisions often need to be made faster than the books can close.

We’re not just doing accounting—we’re building financial intelligence platforms that allow cannabis companies to scale responsibly, attract capital, and stay ahead of the compliance curve.

Question 2

Where do you see the most exciting opportunity for growth and innovation in cannabis?

The most exciting opportunity right now lies at the intersection of data, retail, and product innovation—particularly in how operators use data to drive consumer experience and profitability.

As the market matures and pricing compresses, brands and retailers that understand their customer on a granular level—what they buy, when they buy it, and why—will win. We’re seeing a shift toward more sophisticated, data-backed merchandising strategies, demand forecasting, and dynamic pricing models. That’s where Tuross Group is investing heavily: in building systems that give our clients real-time insights that go far beyond traditional financial reporting.

On the product side, I believe cannabis beverages, minor cannabinoids, and functional formulations (like sleep aids and wellness products) are just getting started. These categories invite mainstream adoption and open the door to broader demographics. But they’ll require smarter inventory systems, tighter manufacturing controls, and better margin management—areas where we already support clients today.

Innovation isn’t just about product—it’s about how efficiently and intelligently companies are run. That’s the next frontier, and that’s where we’re helping operators transform.

Question 3

What’s one piece of advice you would give to someone looking to break into the cannabis industry?

Come in with eyes wide open—and lead with value. Cannabis is not the gold rush people imagined a few years ago. It’s a highly regulated, capital-intensive, margin-compressed industry that requires grit, agility, and operational excellence to survive, let alone succeed.

If you’re coming from another sector, bring your expertise but leave the ego. Whether it’s finance, logistics, retail, or compliance—this industry needs sharp people who can adapt their skills to a uniquely complex environment.

At Tuross Group, we’ve seen firsthand that the companies and individuals who thrive are the ones who understand how to marry compliance with creativity, and structure with speed. If you can solve real problems—cash flow, compliance, scaling, or systems—there’s absolutely room for you in this industry.

And one more thing: relationships matter. This industry is still small, still collaborative, and your reputation will precede you—good or bad. Lead with integrity, and the rest follows.

Question 4

What is the most important thing you have learned from your experiences in the cannabis industry?

The most important thing I’ve learned is that resilience and adaptability are non-negotiable.

Cannabis is unlike any other industry I’ve worked in. The rules change constantly—sometimes without notice. What worked yesterday may not work tomorrow. Operators are navigating 280E tax burdens, limited access to banking, fragmented state regulations, and volatile pricing—all while trying to build real businesses with real margins.

At Tuross Group, we’ve built our entire model around helping operators survive and scale in this kind of chaos. And what I’ve learned is that the most successful businesses are the ones that can adapt quickly—whether that means pivoting product lines, restructuring entities, or doubling down on cost control and data.

But beyond the business mechanics, I’ve also learned that this industry is deeply personal. Most founders got into this space because they care about the plant, the patients, and the broader mission. So it’s not just about profits—it’s about building something that matters, often in the face of enormous headwinds.

That mix of heart and hustle is what makes cannabis such a powerful—and humbling—place to work.

Question 5

What do you want your legacy to be as it relates to the cannabis industry?

I want my legacy to be that we brought real structure, trust, and professionalism to an industry that desperately needed it.

When we started Tuross Group, it was clear that many cannabis businesses—despite being built by smart, passionate operators—were flying blind financially. They didn’t have the systems, the data, or the strategic support they needed to truly scale or attract meaningful investment. I wanted to change that.

My goal has always been to help cannabis operators run their businesses like any other high-performing company—with clean books, forward-looking strategy, and confidence in their numbers. We’ve worked hard to bring Wall Street-level discipline to Main Street cannabis.

But beyond just numbers, I hope the mark we leave is one of integrity. That we were the team that showed up, rolled up our sleeves, and helped founders succeed in a brutally tough industry—while never losing sight of the mission behind the plant.

If we’ve helped even a handful of operators stay in the game, grow responsibly, and take care of their people, I’ll be proud of that legacy.

en_USEnglish
BEARD BROS PHARMS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.